臨床外科67巻8号

2012年08月発行

特集 知っておきたい放射線・粒子線治療

直腸癌・肛門癌に対する放射線治療の現況と展望

著者： 唐澤克之¹

所属機関： ¹がん・感染症センター都立駒込病院放射線科

ページ範囲：P.998 - P.1002

【ポイント】

◆肛門の扁平上皮癌は化学放射線療法に感受性が高く，手術を検討する前に化学放射線療法を検討すべきである．

◆直腸癌・肛門癌ともに化学放射線療法による有害事象で懸念される臓器が小腸である．体位の工夫とともにIMRTの導入が望まれる．

◆局所進行直腸癌に対しては術前に化学放射線療法が行われる．1～3割のCaseでpCRが期待される．

参考文献

1）National Comprehensive Cancer Network；rectal cancer　http://www.nccn.org/professionals/physician_gls/PDF/rectal.pdf

2）Sauer R, Becker H, Hohenberger W, et al：Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351：1731-1740, 2004

3）Mohiuddin M, Marks J, Marks G：Management of rectal cancer：short- vs. long-course preoperative radiation. Int J Radiat Oncol Biol Phys 72：636-643, 2008

4）Gunderson LL, Martin JK, Bèart RW, et al：Intraoperative and external beam irradiation for locally advanced colorectal cancer. Ann Surg 207：52-60, 1988

Delaney TF, Kooy HM（eds）：Proton and charged particle radiotherapy. Philadelphia, Lippincott, William & Wilkins, 2008, pp229-241

6）Dewdney A, Cunningham D, Tabernero J, et al：Multicenter Randomized Phase Ⅱ Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer（EXPERT-C）. J Clin Oncol 30：1620-1627, 2012

7）Willett CG, Duda DG, di Tomaso E, et al：Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer：a multidisciplinary phase Ⅱ study. J Clin Oncol 27：3020-3026, 2009

8）Samuelian JM, Callister MD, Ashman JB, et al：Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 82：1981-1987, 2012

9）Belkacémi Y, Berger C, Poortmans P, et al：Management of primary anal canal adenocarcinoma：a large retrospective study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys 56：1274-1283, 2003

10）Nigro ND, Vaitkevicius VK, Considine B Jr：Combined therapy for cancer of the anal canal：a preliminary report. Dis Colon Rectum 17：354-356, 1974

11）Epidermoid anal cancer：results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 348：1049-1054, 1996

12）Bartelink H, Roelofsen F, Eschwege F, et al：Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer：results of a phase Ⅲ randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15：2040-2049, 1997

13）Flam M, John M, Pajak TF, et al：Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal：results of a phase Ⅲ randomized intergroup study. J Clin Oncol 14：2527-2539, 1996

14）Ajani JA, Winter KA, Gunderson LL, et al：Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal：a randomized controlled trial. JAMA 299：1914-1921, 2008

15）National Comprehensive Cancer Network；anal cancer　http://www.nccn.org/professionals/physician_gls/PDF/anal.pdf

16）James R, Wan S, Glynne-Jones D, et al；National Cancer Research Institute（NCRI）ACTⅡ Trial Management Group：A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus（ACTⅡ）. J Clin Oncol 27：18s,（suppl；abstr LBA4009）, 2009

17）Kachnic LA, Winter K, Myerson R, et al. RTOG 0529：A phase Ⅱ evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 75：S5, 2009